Exploring the active site of phenylethanolamine N-methyltransferase with 1,2,3,4-tetrahydrobenz[h] isoquinoline inhibitors
Exploring the active site of phenylethanolamine N-methyltransferase with 1,2,3,4-tetrahydrobenz[h] isoquinoline inhibitors
复制标题
DOI:
10.1016/j.bmc.2006.11.010
复制
发表时间:
2007-02-01
影响因子:
3.5
通讯作者:
Criscione, Kevin R.
中科院分区:
文献类型:
--
作者:
Grunewald, Gary L.;Seim, Mitchell R.;Criscione, Kevin R.
1,2,3,4-Tetrahydrobenz[h]isoquinoline (THBQ, 11) is a potent, inhibitor of phenylethanolamine N-methyltransferase (PNMT). Docking studies indicated that the enhanced PNMT inhibitory potency of 11 (hPNMT K-i = 0.49 mu M) versus 1,2,3,4-tetrahydroisoquinoline (5, hPNMT Ki = 5.8 mu M) was likely due to hydrophobic interactions with Val53, Met258, Val272, and Val269 in the PNMT active site. These studies also suggested that the addition of substituents to the 7-position of 11 that are capable of forming hydrogen bonds to the enzyme could lead to compounds (14-18) having enhanced PNMT inhibitory potency. However, these compounds are in fact less potent at PNMT than 11. Furthermore, 7-bromo-THBQ (19, hPNMT Ki = 0.22 mM), which has a lipophilic 7-substituent that cannot hydrogen bond to the enzyme, is twice as potent at PNMT than 11. This once again illustrates the limitations of docking studies for lead optimization. (c) 2006 Elsevier Ltd. All rights reserved.